Influenza-attributable burden in United Kingdom primary care

Epidemiol Infect. 2016 Feb;144(3):537-47. doi: 10.1017/S0950268815001119. Epub 2015 Jul 13.

Abstract

Influenza is rarely laboratory-confirmed and the outpatient influenza burden is rarely studied due to a lack of suitable data. We used the Clinical Practice Research Datalink (CPRD) and surveillance data from Public Health England in a linear regression model to assess the number of persons consulting UK general practitioners (GP episodes) for respiratory illness, otitis media and antibiotic prescriptions attributable to influenza during 14 seasons, 1995-2009. In CPRD we ascertained influenza vaccination status in each season and risk status (conditions associated with severe influenza outcomes). Seasonal mean estimates of influenza-attributable GP episodes in the UK were 857 996 for respiratory disease including 68 777 for otitis media, with wide inter-seasonal variability. In an average season, 2·4%/0·5% of children aged <5 years and 1·3%/0·1% of seniors aged ⩾75 years had a GP episode for respiratory illness attributed to influenza A/B. Two-thirds of influenza-attributable GP episodes were estimated to result in prescription of antibiotics. These estimates are substantially greater than those derived from clinically reported influenza-like illness in surveillance programmes. Because health service costs of influenza are largely borne in general practice, these are important findings for cost-benefit assessment of influenza vaccination programmes.

Trial registration: ClinicalTrials.gov NCT01520935.

Keywords: Epidemiology; GP surveillance systems; infectious disease; influenza; influenza vaccines.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Anti-Bacterial Agents
  • Child
  • Child, Preschool
  • Comorbidity
  • Databases, Factual
  • Drug Prescriptions / statistics & numerical data
  • General Practice / statistics & numerical data*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Influenza A virus*
  • Influenza B virus*
  • Influenza Vaccines
  • Influenza, Human / epidemiology*
  • Influenza, Human / prevention & control
  • Influenza, Human / virology
  • Middle Aged
  • Otitis Media / drug therapy
  • Otitis Media / epidemiology*
  • Otitis Media / virology
  • Primary Health Care / statistics & numerical data*
  • Seasons
  • United Kingdom / epidemiology
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Influenza Vaccines

Associated data

  • ClinicalTrials.gov/NCT01520935